Opportunities for growth in self testing & pharmacogenetics
This article was originally published in Clinica
Executive Summary
The global market for IVD products is undergoing a significant transition, driven by the advent of new analytical technologies and developments in genomics and proteomics that are beginning to expand the scope of diagnostic testing and its role in healthcare, writes Philip Greenfield.